Saturday, December 05, 2015 9:25:52 AM
Consulting 799,459 621,871 2,626,513 1,040,397
Officer Compensation — 636,130 —
Professional Fees 27,097 62,014 98,369 144,439
Research and Development 37,612 — 144,729 —
General and Administration 19,393 15,872 48,905 91,251
Total Operating Expenses 883,561 699,757 3,554,646 1,276,087
Operating Loss (871,580 ) (699,397 ) (3,542,665 ) (1,225,727 )
These are figures directly from the 10Q notice the money spent on consulting. Then look at R&D. I know you base alot on assumtions and hope. Try using facts. The majority of money was NOT spent on devleloping the product as you assume. READ THE FILINGS!
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM